Division of Genetic Therapeutics, Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan.
Gene Ther. 2012 May;19(5):476-82. doi: 10.1038/gt.2011.183. Epub 2011 Nov 24.
Varying degrees of metabolic abnormalities mediated by chronic inflammation are implicated in the chronic glomerular injuries associated with obesity. Interleukin (IL)-10, a pleiotropic cytokine, exerts anti-inflammatory effects in numerous biological settings. In the present study, we explored the biological benefits of adeno-associated virus (AAV) vector-mediated sustained IL-10 expression against the pathological renal characteristics observed in Zucker fatty rats (ZFRs). We injected an AAV vector, encoding rat IL-10 or enhanced green fluorescent protein (GFP) into male ZFRs at 5 weeks of age. Subsequently, the renal pathophysiological changes were analyzed. Persistent IL-10 expression significantly reduced the urinary protein excretion of ZFRs compared with GFP expression (47.1±11.6 mg per mg·creatinine versus 88.8±30.0 mg per mg·creatinine, P<0.01). The serum levels of IL-10 negatively correlated with the urinary protein in AAV-treated rats (r=-0.78, P<0.01). Renal hypertrophy, increased widths in the glomerular basement membrane, and the lack of uniformity and regularity of the foot process of the visceral glomerular epithelial cells of ZFRs were significantly blunted by IL-10 expression. IL-10 also abrogated the downregulation of glomerular nephrin observed in ZFRs treated with the GFP vector. Our findings provide insights into the potential benefit of the anti-inflammatory effects of IL-10 on the overall management of glomerulopathy induced by the metabolic disorders associated with obesity.
慢性炎症介导的代谢异常程度与肥胖相关的慢性肾小球损伤有关。白细胞介素 (IL)-10 是一种多效细胞因子,在许多生物学环境中发挥抗炎作用。在本研究中,我们探讨了腺相关病毒 (AAV) 载体介导的持续 IL-10 表达对 Zucker 肥胖大鼠 (ZFR) 观察到的病理性肾脏特征的生物学益处。我们在雄性 ZFR 出生后 5 周时注射编码大鼠 IL-10 或增强型绿色荧光蛋白 (GFP) 的 AAV 载体。随后,分析了肾脏病理生理变化。与 GFP 表达相比,持续的 IL-10 表达显著降低了 ZFR 的尿蛋白排泄 (47.1±11.6 毫克/毫克肌酐与 88.8±30.0 毫克/毫克肌酐,P<0.01)。AAV 治疗大鼠的血清 IL-10 水平与尿蛋白呈负相关 (r=-0.78,P<0.01)。IL-10 还减弱了 ZFR 中肾小球基底膜宽度增加以及内脏肾小球上皮细胞足突均匀性和规则性丧失。IL-10 还消除了 GFP 载体治疗的 ZFR 中肾小球nephrin 的下调。我们的研究结果提供了关于 IL-10 抗炎作用对肥胖相关代谢紊乱引起的肾小球病整体管理的潜在益处的见解。